NEW DELHI: The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump’s announcement to impose tariffs of up to 100 pc on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.

In a weekly briefing, MEA Spokesperson Randhir Jaiswal stated that relevant ministries and departments are monitoring the situation and examining its potential effects.

“We saw a notice yesterday on social media that talked about new tariffs. We’ve seen the report on pharma and other products, and the relevant ministry and department are closely monitoring the matter and examining its impact,” Jaiswal said.

The tariffs specifically target branded and patented pharmaceuticals, potentially affecting multinational pharmace

See Full Page